TITLE

SINOBIOPHARMA SIGNS PACT TO MANUFACTURE/CO-PROMOTE PRODUCT

PUB. DATE
September 2010
SOURCE
Worldwide Biotech;Sep2010, Vol. 22 Issue 9, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that Sinobiopharma Inc. has signed an agreement with Anhui Xianfeng Pharmaceuticals Co. Ltd. for the manufacture and co-marketing of the antibiotic Clindamycin and the parenteral nutrition L-alanyl-L-glutamine. Terms of the agreement include Sinobiopharma's ownership of both products' drug certificates, drug registration approval documents and production technologies. Sinobiopharma chief executive officer (CEO) and chairman Lequn Lee Huang also describes the company's drug manufacturing facilities.
ACCESSION #
53281242

 

Related Articles

  • Colaboradores que aparecen en los agradecimientos: olvido y reconocimiento de un incumplimiento. Juana-Roa, J.; Wanden-Berghe, C.; Sanz-Valero, J. // Nutricion Hospitalaria;jul/ago2011, Vol. 26 Issue 4, p927 

    No abstract available.

  • Feeding formulas. Eisenberg, Patti G.; O'Connor, Eileen // RN;Dec94, Vol. 57 Issue 12, p46 

    Provides information on selection and administration of formula in parenteral feeding. Importance of key ingredients of feeding formulas; Osmolality; Caloric density of the formula; Calculation of the number of calories needed by the patient; Prevention of fluid loss; Prevention and treatment...

  • Measuring pH to make sure feeding tubes haven't gone astray. Begany, Timothy // RN;Apr94, Vol. 57 Issue 4, p20 

    Reports on the development of a bedside test by Norma Metheny and researchers to determine if nasogastric and nasointestinal feeding tubes have been positioned properly. Measurement of pH of aspirates from the newly inserted feeding tube; Use of measurement to determine if the tube is in the...

  • The ABCs of TPN. Gianino, Stephanie; Seltzer, Rene; Eisenberg, Patti // RN;Feb96, Vol. 59 Issue 2, p42 

    Focuses on techniques to maximize the benefits and minimize the risks of total parenteral nutrition (TPN). Identification of patients who will get the most benefit from TPN; Maintenance of the catheter; Administration of TPN formula; Prevention of refeeding syndrome; Description of reaction by...

  • nPCR assessment and IDPN treatment of malnutrition in pediatric hemodialysis patients. Goldstein, Stuart L.; Baronette, Shannon; Gambrell, Vital; Currier, Helen; Brewer, Eileen D. // Pediatric Nephrology;Jul2002, Vol. 17 Issue 7, p531 

    Very few pediatric studies have monitored nutritional status using normalized protein catabolic rate (nPCR) or treating protein-energy malnutrition (PEM) with intradialytic parenteral nutrition (IDPN). The current study compares nPCR with serum albumin as a marker for nutritional status and...

  • When you think your patient needs TPN. Cerrato, Paul L. // RN;May85, Vol. 48 Issue 5, p79 

    Presents information on total parenteral nutrition (TPN). Patient who needs TPN; Use of TPN for gut failure; Options for treating several malnutrition.

  • Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients. Cherry, Nancy; Shalansky, Karen // American Journal of Health-System Pharmacy;9/15/2002, Vol. 59 Issue 18, p1736 

    Examines the efficacy of intradialytic parenteral nutrition (IDPN) in malnourished hemodialysis patients. IDPN formulation; Analysis of dry body weights; Serum albumin levels.

  • Safety first. Blank, Christine // Drug Topics;2/16/98, Vol. 124 Issue 4, p50 

    Reports that the American Society for Parenteral and Enteral Nutrition (ASPEN) will release guidelines for the preparation of Total Parenteral Nutrition (TPN). Proposed effects of these guidelines; Impact of the lack of standardized labels and guidelines; Comment from Jay Mirtallo, chairman of...

  • Avoidance and Management of Complications of Total Parenteral Nutrition. Khaodhiar, Lalita; Bistrian, Bruce R. // Nutrition in Clinical Care;Jul/Aug99, Vol. 2 Issue 4, p239 

    Abstract Total parenteral nutrition therapy can be life-saving for specific groups of patients, but is not without risks. Complications that may occur are divided into three groups: mechanical, infectious, and metabolic. While mechanical complications related to central venous catheter placement...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics